

05 Dec 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sobi-to-showcase-scientific-advances-and-commitment-to-haematology-at-ash-2025-302634280.html

04 Dec 2025
// PHARMIWEB
https://www.pharmiweb.com/press-release/2025-12-04/the-new-england-journal-of-medicine-publishes-positive-phase-3-valiant-results-of-pegcetacoplan-for-c3g-and-primary-ic-mpgn

03 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/03/3199410/0/en/The-New-England-Journal-of-Medicine-Publishes-Positive-Phase-3-VALIANT-Results-of-EMPAVELI-pegcetacoplan-for-C3G-and-Primary-IC-MPGN.html

12 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/12/3186065/0/en/Apellis-Announces-5-Year-GALE-Data-Showing-SYFOVRE-pegcetacoplan-injection-Delayed-Progression-of-Geographic-Atrophy-by-1-5-Years.html

20 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/20/3169219/0/en/New-One-Year-Data-Reinforcing-the-Robust-and-Sustained-Efficacy-of-EMPAVELI-pegcetacoplan-in-C3G-and-Primary-IC-MPGN-to-be-Presented-at-ASN-Kidney-Week.html

29 Jul 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/apellis-counters-novartis-broad-label-empaveli-kidney-disease